Shares of Axsome Therapeutics (NASDAQ: NASDAQ:AXSM) fell on Monday following the U.S. FDA's decision to not review the ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ('Formosa', 6838.TW), today announced a licensing agreement, whereby Harrow has ...

Bitcoin’s success reflects a growing shift in how the world approaches not only cryptocurrency but also financial markets as ...

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

How Rick Carter, producer designer of blockbusters for Steven Spielberg and Jim Cameron, sees GenAI emerging as a ...

RBI's big beautiful monetary policy, rising market activity a cause for concern, global growth slows but markets are soaring, ...

The Nations League final wasn’t Lamine Yamal’s finest hour considering the ridiculous standards that he’d set himself over ...

Critics say renewables can't provide stable power. Supporters say we just need better equipment. Both sides are wrong. We ...

More than 15 years ago, my family doctor awakened me to a new world. “You have blood cancer,” she said. “But we may have ways ...

An introduction of the City of Yankton’s new comprehensive plan and an update on the Paradigm Industries project top the agenda of Monday’s Yankton City Commission meeting. Please log in, or sign up ...